Hengehold Capital Management LLC Boosts Stake in Cigna Group $CI

Hengehold Capital Management LLC grew its stake in Cigna Group (NYSE:CI) by 4.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,054 shares of the health services provider’s stock after buying an additional 95 shares during the period. Hengehold Capital Management LLC’s holdings in Cigna Group were worth $679,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in CI. Price T Rowe Associates Inc. MD grew its stake in Cigna Group by 10.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 12,056,806 shares of the health services provider’s stock valued at $3,966,690,000 after acquiring an additional 1,094,327 shares in the last quarter. Massachusetts Financial Services Co. MA increased its holdings in Cigna Group by 0.9% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 11,654,993 shares of the health services provider’s stock worth $3,834,493,000 after acquiring an additional 98,715 shares in the last quarter. Dodge & Cox grew its position in shares of Cigna Group by 1.3% in the first quarter. Dodge & Cox now owns 8,889,733 shares of the health services provider’s stock valued at $2,924,722,000 after purchasing an additional 117,125 shares in the last quarter. GQG Partners LLC boosted its stake in shares of Cigna Group by 21.5% in the first quarter. GQG Partners LLC now owns 4,886,674 shares of the health services provider’s stock valued at $1,607,716,000 after purchasing an additional 865,092 shares during the period. Finally, Parnassus Investments LLC lifted its stake in Cigna Group by 3.1% during the first quarter. Parnassus Investments LLC now owns 2,885,583 shares of the health services provider’s stock worth $949,357,000 after purchasing an additional 86,602 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

Shares of CI opened at $286.04 on Friday. The stock has a market capitalization of $76.35 billion, a PE ratio of 15.61, a PEG ratio of 0.84 and a beta of 0.48. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The company has a 50 day moving average price of $292.71 and a 200-day moving average price of $310.50. Cigna Group has a fifty-two week low of $256.89 and a fifty-two week high of $358.88.

Cigna Group (NYSE:CI) last announced its earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating analysts’ consensus estimates of $7.15 by $0.05. The business had revenue of $67.13 billion during the quarter, compared to analysts’ expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The business’s revenue was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts predict that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Stockholders of record on Thursday, September 4th were issued a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend was Thursday, September 4th. Cigna Group’s payout ratio is 32.97%.

Insider Buying and Selling at Cigna Group

In other news, insider Nicole S. Jones sold 28,526 shares of the stock in a transaction on Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the sale, the insider owned 25,648 shares of the company’s stock, valued at $7,694,400. This represents a 52.66% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.70% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. Cantor Fitzgerald reissued an “overweight” rating and set a $365.00 price objective on shares of Cigna Group in a research note on Tuesday, August 26th. Guggenheim reaffirmed a “buy” rating and set a $350.00 price objective (down from $388.00) on shares of Cigna Group in a report on Monday, August 4th. Barclays raised their target price on shares of Cigna Group from $354.00 to $383.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $371.00 price objective on shares of Cigna Group in a report on Thursday, June 26th. Finally, Wells Fargo & Company dropped their target price on shares of Cigna Group from $341.00 to $340.00 and set an “equal weight” rating on the stock in a research report on Thursday, August 14th. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $371.81.

About Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.